Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2012-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijrobp.2012.01.013PMID 22436781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy

  2011cited by this paper
• Radiation dose-volume effects in the stomach and small bowel.

  2010cited by this paper
• Patient‐reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer

  2010cited by this paper
• Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model.

  2010cited by this paper
• Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial.

  2010cited by this paper
• The missing voice of patients in drug-safety reporting.

  2010cited by this paper
• Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer

  2007cited by this paper
• Patient‐reported Outcomes in Cancer: A Review of Recent Research and Policy Initiatives

  2007cited by this paper
• Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making.

  2007cited by this paper
• Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning.

  2006cited by this paper
• Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group.

  2004cited by this paper
• Quality of life during radiotherapy for rectal cancer.

  2003cited by this paper
• The dose-volume realationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer

  2002cited by this paper
• The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer.

  2002cited by this paper
• Symptom Indexes to Assess Outcomes of Treatment for Early Prostate Cancer

  2001cited by this paper
• Adjuvant versus Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer A Progress Report of a Phase-III Randomized Trial (Protocol CAO/ARO/AIO-94)

  2001cited by this paper
• Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma.

  1998cited by this paper

• ESTRO technical guideline: intensity modulated radiotherapy and image guided radiotherapy for rectal cancer.

  2026cites this paper
• Gastrointestinal Toxicity and Clinical Predictors of Total Neoadjuvant Therapy in Rectal Cancer: A Real-World Retrospective Study

  2026cites this paper
• Strategies to reduce intestinal toxicity in neoadjuvant management of locally advanced rectal cancer

  2025cites this paper
• Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: bowel dose-volume effect quantification in a multicentric cohort study.

  2021cites this paper
• Oral contrast agents lead to underestimation of dose calculation in volumetric-modulated arc therapy planning for pelvic irradiation

  2020cites this paper
• Patient-reported acute GI symptoms in locally advanced cervical cancer patients correlate with rectal dose.

  2020cites this paper
• Proton beam radiotherapy for anal and rectal cancers.

  2020cites this paper
• Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action

  2020cites this paper
• Systematic review and meta-analysis of small bowel dose-volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy.

  2019cites this paper
• A novel dynamic arc treatment planning solution to reduce dose to small bowel in preoperative radiotherapy for rectal cancer.

  2019cites this paper
• Will There Be a Clinically Significant Role for Protons in Patients With Gastrointestinal Malignancies?

  2018cites this paper
• Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG).

  2018cites this paper
• A prospective cohort study of patient-reported vomiting, retching, nausea and antiemetic use during neoadjuvant long-course radiation therapy and concurrent 5-fluorouracil-based chemotherapy for rectal adenocarcinoma

  2018cites this paper
• Factors Contributing to Variation in the Management of Radiation Therapy-Induced Nausea and Vomiting

  2017cites this paper
• Correlation between bone marrow dose volumes and acute hematological toxicity in postoperative gynecological cancer patients

  2016cites this paper
• Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma.

  2016cites this paper
• Dosimetric Comparison between Intensity Modulated Radiotherapy and 3 Dimensional Conformal Radiotherapy in the Treatment of Rectal Cancer

  2016cites this paper
• Nausea and vomiting induced by gastrointestinal radiation therapy: current status and future directions

  2015cites this paper
• Use of Proktis-M suppositories in patients undergoing neoadjuvant radiochemotherapy for adenocarcinoma of the rectum.

  2015cites this paper
• A randomized study of the effect of patient positioning on setup reproducibility and dose distribution to organs at risk in radiotherapy of rectal cancer patients

  2015cites this paper
• NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer.

  2015cites this paper
• Gastrointestinal Cancer: Nonliver Proton Therapy for Gastrointestinal Cancers

  2014cites this paper
• Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer.

  2013cites this paper
• Rectal and Anal Cancer

  2013cites this paper
• Feasibility of Image-Guided Radiotherapy for Elderly Patients with Locally Advanced Rectal Cancer

  2013cites this paper